Compare Affirm Holdings Inc (AFRM) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs Revvity Inc — how do they compare? Affirm Holdings Inc trades at $73.44 (market cap $25.69B), while Revvity Inc trades at $116.91 (market cap $12.91B). The key difference: Affirm Holdings Inc is the larger of the two by market cap, and Revvity Inc pays a 0.24% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.
| AFRM | RVTY | |
|---|---|---|
Market Cap | $25.69B | $12.91B |
Sector | Financials | Technology |
52-Week High | $92.18 | $117.75 |
52-Week Low | $42.53 | $82.26 |
Enterprise Value | $32.30B | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Affirm Holdings (AFRM) trades at $73.42, down 2.81% on the day, amid a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings expectations in recent quarters, with revenue surging from $1.3B in 2022 to $3.22B in 2025, while achieving positive net income of $52.19M after years of losses. Analyst consensus is strongly bullish with a $95.75 price target, and institutional interest remains high.
AFRM presents a compelling growth story with accelerating profitability and expanding market share in fintech, though elevated valuation multiples and sensitivity to interest rate changes pose risks. The stock's upside potential hinges on sustained execution and macroeconomic stability, making it suitable for growth-oriented investors comfortable with volatility.
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
